Evidence map›Paper›PMID 28892501›Full record

ArticlePLoS neglected tropical diseases2017

Implementation of a study to examine the persistence of Ebola virus in the body fluids of Ebola virus disease survivors in Sierra Leone: Methodology and lessons learned.

Gibrilla Fadlu Deen, Suzanna L R McDonald, Jaclyn E Marrinan, Foday R Sesay, Elizabeth Ervin, Anna E Thorson, Wenbo Xu, Ute Ströher, Patricia Ongpin, Neetu Abad and 12 more

Open access · goldAbstract read
In one paragraph

Article in PLoS neglected tropical diseases, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Gibrilla Fadlu DeenClinical Studies, Internal Medicine, Connaught Hospital, Ministry of Health and Sanitation, Freetown, Sierra Leone.
Suzanna L R McDonaldComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.ORCID 0000-0003-2363-2812
Jaclyn E MarrinanComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Foday R Sesay34 Military Hospital, Sierra Leone Ministry of Defence, Freetown, Sierra Leone.
Elizabeth ErvinViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Anna E ThorsonDepartment of Reproductive Health and Research, Family, Women's and Children's Health, World Health Organization, Geneva, Switzerland.
Wenbo XuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Ute StröherViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Patricia OngpinStrategic information, Joint United Nations Programme on HIV/AIDS, Freetown, Sierra Leone.
Neetu AbadSocial & Behavioral Research and Evaluation Branch, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Archchun AriyarajahComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Tasneem MalikOffice of Global Activities, Division of Sexually Transmitted Disease Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, & TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Hongtu LiuNational Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China.
Christine RossHIV Care and Treatment Branch, Division of Global HIV/AIDS and Tuberculosis, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Kara N DurskiPandemic and Epidemic Disease Department, Outbreaks and Health Emergencies, World Health Organization, Geneva, Switzerland.
Philippe GaillardComprehensive Care & Support for EVD Survivors, EVD Research, World Health Organization, Freetown, Sierra Leone.
Oliver MorganDivision of Global Health Protection, Center for Global Health, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Pierre FormentyPandemic and Epidemic Disease Department, Outbreaks and Health Emergencies, World Health Organization, Geneva, Switzerland.
Barbara KnustViral Special Pathogens Branch, Division of High Consequence Pathogens and Pathology, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, United States of America.
Nathalie BroutetDepartment of Reproductive Health and Research, Family, Women's and Children's Health, World Health Organization, Geneva, Switzerland.
Foday Sahr34 Military Hospital, Sierra Leone Ministry of Defence, Freetown, Sierra Leone.
Sierra Leone Ebola Virus Persistence Study Group
Centers for Disease Control and Prevention · USWorld Health Organization · CHMinistry of Defence · SLNational Institute for Viral Disease Control and Prevention · CNMinistry of Health and Sanitation · SL

Funding

World Health Organization 001
6 · The paper itself

Abstract

backgroundThe 2013-2016 West African Ebola virus disease epidemic was unprecedented in terms of the number of cases and survivors. Prior to this epidemic there was limited data available on the persistence of Ebola virus in survivors' body fluids and the potential risk of transmission, including sexual transmission. METHODOLOGY/PRINCIPAL

findingsGiven the urgent need to determine the persistence of Ebola virus in survivors' body fluids, an observational cohort study was designed and implemented during the epidemic response operation in Sierra Leone. This publication describes study implementation methodology and the key lessons learned. Challenges encountered during implementation included unforeseen duration of follow-up, complexity of interpreting and communicating laboratory results to survivors, and the urgency of translating research findings into public health practice. Strong community engagement helped rapidly implement the study during the epidemic. The study was conducted in two phases. The first phase was initiated within five months of initial protocol discussions and assessed persistence of Ebola virus in semen of 100 adult men. The second phase assessed the persistence of virus in multiple body fluids (semen or vaginal fluid, menstrual blood, breast milk, and urine, rectal fluid, sweat, saliva, tears), of 120 men and 120 women. CONCLUSION/SIGNIFICANCE: Data from this study informed national and global guidelines in real time and demonstrated the need to implement semen testing programs among Ebola virus disease survivors. The lessons learned and study tools developed accelerated the implementation of such programs in Ebola virus disease affected countries, and also informed studies examining persistence of Zika virus. Research is a vital component of the public health response to an epidemic of a poorly characterized disease. Adequate resources should be rapidly made available to answer critical research questions, in order to better inform response efforts.

Indexed as

AdultAgedAged, 80 and overBody FluidsCohort StudiesEbolavirusFemaleHemorrhagic Fever, EbolaHumansMaleMiddle AgedSierra LeoneSurvivorsTime FactorsYoung Adult

Identifiers

PMID28892501
PMCPMC5593174
OpenAlexW2754106068

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.